United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine

Clinical Research |  News | 0 Comment | 17 Jan, 2019

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders has announced positive top-line results from its Phase 2a...Read more

Bridge Bio receives FDA ODD for IPF drug

Clinical Research |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the U.S. Food and Dr...Read more

Immunocore names David Berman as Head of R&D

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development. Over his career, David has worked on immuno-oncology programmes at ...Read more

Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the first patient has been successfully dosed in a pha...Read more

NIH starts clinical trial for FMT

Clinical Research |  News | 0 Comment | 15 Jan, 2019

A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema—putting stool from a healthy donor...Read more

UroGen Pharma announces positive results of UGN-101

Clinical Research |  News | 0 Comment | 14 Jan, 2019

A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has announced topline results from the ongoing pivotal Phase 3 OLYMPUS cl...Read more

CellMax, Medigen partner for cell therapy clinical trials

Clinical Research |  News | 0 Comment | 11 Jan, 2019

CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood, has been named as a partner in Taiwan based Medigen Biotech’s...Read more

Forbius announces the first patient dosed in a Phase 1 trial of AVID200

Clinical Research |  News | 0 Comment | 09 Jan, 2019

Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the first patient was dosed in a Phase 1 clinical trial with AVID200. The tri...Read more

Immutep collaborates with CYTLIMIC

Clinical Research |  News | 0 Comment | 08 Jan, 2019

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and a service agreement with CYTLIMIC Inc.  for its lead product can...Read more

Solasia initiates Phase III programme for PledOx

Clinical Research |  News | 0 Comment | 07 Jan, 2019

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Solasia acquired exclusive development and commercialization rights for ...Read more

USFDA approves Portola Pharmaceuticals’ Andexxa®

Clinical Research |  News | 0 Comment | 03 Jan, 2019

Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval Supplement (PAS) for its large-scale, second generatio...Read more

Apellis Pharmaceuticals provides update on its Phase 3 program

Clinical Research |  News | 0 Comment | 01 Jan, 2019

Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with Geographic Atrophy (GA). Apellis expects to be able to restart enro...Read more

Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA

Clinical Research |  News | 0 Comment | 01 Jan, 2019

Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat diseases through inhibition of the complemen...Read more

Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate

Clinical Research |  News | 0 Comment | 28 Dec, 2018

Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that the company has successfully activated clinical study sites for the Ph...Read more

Vedanta Biosciences Initiates Phase 2 Study for VE303

Clinical Research |  News | 0 Comment | 27 Dec, 2018

Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria ha...Read more

Merck, Pfizer to terminate Phase III JAVELIN Ovarian 100 trial of avelumab

Clinical Research |  News | 0 Comment | 26 Dec, 2018

Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothesis, and the...Read more

Patrys’s drug suppresses breast cancer brain metastases, increases survival

Clinical Research |  News | 0 Comment | 24 Dec, 2018

Singapore -  Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinical data for its drug candidate PAT-DX1, Patrys’ humanized versio...Read more

Weight change in middle-aged and elderly Singaporean Chinese linked to increased mortality risk

Clinical Research |  News | 0 Comment | 18 Dec, 2018

Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, among middle-aged and elderly Chinese Singaporeans are linked to increase...Read more